Development of the method for determinating ADCC biological activity of IVIG

Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 2

Abstract

Objective To establish a method for determinating the antigen-dependent cell-mediated cytotoxicity (ADCC) of human immunoglobulin (pH4)for intravenous injection (IVIG) on luciferase reporter gene-modified cell assay. Methods As effector cells, Jurkat-NFAT-Luc-CD16 cells were used in the assay, and PLC/PRF/5 cells were used as target cells. After incubation of effector cells and target cells with IVIG, the method for determinating ADCC biological activity of IVIG was established by detecting luciferase released by activated T nuclear factor after binding of IVIG Fc fragment to effector cells. Meanwhile, the experimental assay conditions were optimized, and the methodology was verified subsequently. Results IVIG had a dose-response relationship in this method, which was consistent with four parameter logistic model. And the PLC/PRF/5 cells were finally determined as the target cells. The initial dilution concentration of antibody was 20 mg/mL, and the ratio dilution was 1∶2, and the effector to target ratio was 1∶3, and co-incubation time of two cells and IVIG was 24 hours. Within-run and between-run analysis including three independent tests, initial working concentration relative light unit (RLU) and the relative standard deviation (RSD) of the concentration for 50% of maximal effect(EC50) were less than 11%. The relative titers of the recovery samples of the two different dilution groups were (23.50±1.69)% and (49.30±2.97)%, respectively, and the corresponding recovery rates were (93.50±6.30)% and (96.24±5.43)%, respectively, with RSD less than 11%. Conclusion The method for determinating ADCC biological activity of IVIG based on luciferase reporter gene-modified cell assay was successfully established. It could be applied in determinating the ADCC biological activity of IVIG, and has the advantages of satisfactory linearity, accuracy, precision and specificity.

Authors and Affiliations

Liyuan ZHU, Qing LIU, Li MA, Changqing LI

Keywords

Related Articles

Application of recovery autologous blood transfusion combined with bilateral internal iliac artery presetting in high-risk patients with hemorrhage during cesarean section

Objective To explore the effect of recovery autologous blood transfusion combined with bilateral internal iliac artery presetting in high-risk patients with hemorrhage during cesarean section. Methods A total of 162 high...

Analysis on the characteristics of rural blood donation population in Dali Bai Autonomous Prefecture

Objective To explore the status and characteristics of voluntary blood donors in rural areas of Dali Bai Autonomous Prefecture (referred as Dali), and to provide basis for scientific and effective voluntary blood donatio...

Following up and re-entry of HBV reactive blood donors in Yantai area

Objective To analyze the preliminary screening and follow-up testing data of HBV in Yantai area, and discuss the rationality of following up and re-entry program of HBV reactive blood donors. Methods Donors who were sing...

Serological characteristics of HBsAg positive/HBV DNA non-reactive blood donors

Objective To explore the distribution of serological markers related to samples whose serological test results were inconsistent with HBV DNA test results among voluntary blood donors in Xi′an. Methods A total of 71 HBsA...

Clinical observation of autologous platelet rich plasma in the treatment of diabetes foot ulcer

Objective To explore the clinical effect of PRP on refractory ulcer of diabetes foot on the basis of routine treatment. Methods Sixty-four patients who suffered from diabetes foot and treated in our hospital from January...

Download PDF file
  • EP ID EP738481
  • DOI 10.13303/j.cjbt.issn.1004-549x.2023.02.007
  • Views 45
  • Downloads 0

How To Cite

Liyuan ZHU, Qing LIU, Li MA, Changqing LI (2023). Development of the method for determinating ADCC biological activity of IVIG. Chinese Journal of Blood Transfusion, 36(2), -. https://europub.co.uk/articles/-A-738481